Wegovy: cost, evidence, and the honest comparison

Semaglutide mimics GLP-1, a hormone the gut releases after eating. It slows how fast the stomach empties and acts on appetite centres in the brain, which is why most people report eating less without deliberately trying to.

What it's approved for

Chronic weight management in adults and adolescents 12+ with obesity, or overweight with at least one weight-related condition; also approved to reduce major cardiovascular events in adults with established cardiovascular disease and overweight or obesity.

Forms and doses: Once-weekly injection pen (0.25–2.4 mg, plus a 7.2 mg high dose) and, since January 2026, a once-daily oral tablet.

What the research actually shows

In the STEP 1 trial (NEJM, 2021), participants on semaglutide 2.4 mg lost roughly 15% of body weight on average over 68 weeks versus about 2.4% on placebo. The DXA substudy also showed about 10% of lean mass was lost alongside roughly 19% of fat mass — the reason our diet guide is built around protein and resistance training.

Sources: Wilding et al., STEP 1, NEJM 2021 · FDA label information (DailyMed)

Side effects, stated plainly

The most commonly reported effects in trials were gastrointestinal — nausea, diarrhoea, vomiting, constipation — usually worst during dose escalation. Serious warnings on the label include thyroid C-cell tumours in rodents, pancreatitis, and gallbladder disease. Full risk information belongs with your prescriber and the label.

What it costs

Wegovy is where the 2026 price war landed hardest: the manufacturer's own pharmacy sells it for $149–$349 a month depending on form and dose, while telehealth brands resell the same medication at the same med price plus a required membership of about $149 a month.

ChannelForm & doseMedRequired feeTrue monthlyStatus
NovoCare PharmacyLOWEST LISTED pill · 1.5 mg $149 $149 listed
Sesame Care pill · 1.5/4 mg $149 $149 listed
NovoCare Pharmacy pill · 4 mg $199 $199 listed
Hims & Hers pill · from $149 $149 $149/mo $298 listed
Ro (Ro Body) pill · 1.5 mg $149 $149/mo $298 listed
NovoCare Pharmacy pill · 9 mg $299 $299 listed
NovoCare Pharmacy pill · 25 mg $299 $299 listed
Sesame Care pill · 9/25 mg $299 $299 listed
Hims & Hers pen · from $199 $199 $149/mo $348 listed
Ro (Ro Body) pill · 4 mg $199 $149/mo $348 listed
Ro (Ro Body) pen · 0.25/0.5 mg (promo) $199 $149/mo $348 listed
LifeMD pen · starting at $199 $199 $149/mo $348 listed
NovoCare Pharmacy pen · 0.25–2.4 mg (all standard doses) $349 $349 listed
Sesame Care pen · standard doses $349 $349 listed
NovoCare Pharmacy pen · 7.2 mg (high dose) $399 $399 listed
Ro (Ro Body) pill · 9/25 mg $299 $149/mo $448 listed
Ro (Ro Body) pen · 1–2.4 mg $349 $149/mo $498 listed
Ro (Ro Body) pen · 7.2 mg (high dose) $399 $149/mo $548 listed

True monthly = medication plus any required membership fee. Cheapest listed right now: NovoCare Pharmacy at $149/month. Full table and filters on the Wegovy cost page.

Keep reading

Common questions

What is the cheapest legitimate way to get Wegovy?

As of our latest verification, the manufacturer's own pharmacy lists the lowest cash prices — the oral form from $149 a month and the pen at $349, with an intro offer on the first two pen fills. Insurance or Medicare's Bridge copay can beat all of it. Live numbers are on our Wegovy cost page.

Is Wegovy the same as Ozempic?

Both are semaglutide made by the same manufacturer, but they are approved for different things: Wegovy for chronic weight management and cardiovascular risk reduction, Ozempic for type 2 diabetes. They are not interchangeable products and the doses differ.

Do I keep the weight off after stopping?

Trials that withdrew the medication showed most participants regained a substantial share of the weight lost, which is why habit and nutrition work during treatment matters so much. That is a conversation for your prescriber.

Other weight loss medications

Zepbound · Foundayo · Ozempic · Compounded semaglutide · Compounded tirzepatide · Liraglutide

Wegovy market news

2026-07-29
FTC, Utah, and LA County sue Hims & Hers over health-data sharing and cancellation practices

The complaint targets sharing sensitive health data with ad platforms and ROSCA billing/cancellation practices — context for anyone weighing the $149/month membership model.

The Hims dossier →
2026-07-01
Medicare's $50/month GLP-1 Bridge copay goes live

Participating Part D plans now cover Wegovy (pen and pill), Foundayo, and the Zepbound KwikPen at a flat $50 monthly copay through 2027 — below every cash price we track.

How the Bridge actually works →
2026-04-30
FDA moves to permanently end bulk compounding of semaglutide and tirzepatide

The proposed 503B Bulks List exclusion would close the mass-compounding era for good. Patient-specific 503A compounding continues — the legal market our index tracks at $139–$297 all-in.

The surviving market, explained →

All tracked news → · Fed by a daily automated scan; entries publish only after primary-source verification.

Educational and pricing journalism, not medical advice — indications, dosing, and suitability are decisions for you and a licensed clinician, and the FDA label is the authority on risks. Prices carry the verification dates shown; the provider's checkout is the final word. Some links may earn commissions; rankings are ordered by cost, never compensation — disclosure.

Prices here change monthly. Get one email when they do. Free price-drop alerts →